Marble Harbor Investment Counsel’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$324K Hold
5,343
0.04% 151
2025
Q4
$288K Hold
5,343
0.03% 161
2025
Q3
$241K Hold
5,343
0.03% 176
2025
Q2
$247K Sell
5,343
-4,000
-43% -$196K 0.03% 184
2025
Q1
$570K Sell
9,343
-1,400
-13% -$81.6K 0.06% 105
2024
Q4
$608K Sell
10,743
-400
-4% -$22.4K 0.07% 111
2024
Q3
$577K Buy
11,143
+400
+4% +$18.8K 0.06% 128
2024
Q2
$446K Sell
10,743
-1,150
-10% -$51.5K 0.05% 137
2024
Q1
$645K Sell
11,893
-1,325
-10% -$67.5K 0.07% 112
2023
Q4
$678K Sell
13,218
-4,292
-25% -$225K 0.08% 106
2023
Q3
$1.02M Buy
17,510
+42
+0.2% +$2.57K 0.13% 88
2023
Q2
$1.12M Hold
17,468
0.14% 85
2023
Q1
$1.21M Buy
17,468
+500
+3% +$35.3K 0.16% 82
2022
Q4
$1.22M Buy
16,968
+1,187
+8% +$89.5K 0.16% 79
2022
Q3
$1.12M Hold
15,781
0.17% 78
2022
Q2
$1.22M Hold
15,781
0.19% 78
2022
Q1
$1.15M Buy
15,781
+1,500
+11% +$101K 0.14% 89
2021
Q4
$890K Buy
14,281
+403
+3% +$23.6K 0.1% 96
2021
Q3
$821K Hold
13,878
0.11% 95
2021
Q2
$927K Sell
13,878
-300
-2% -$19.6K 0.12% 95
2021
Q1
$895K Buy
14,178
+200
+1% +$12.4K 0.12% 95
2020
Q4
$867K Buy
13,978
+682
+5% +$41.9K 0.13% 92
2020
Q3
$802K Hold
13,296
0.13% 89
2020
Q2
$782K Hold
13,296
0.14% 88
2020
Q1
$741K Buy
13,296
+2,160
+19% +$132K 0.15% 82
2019
Q4
$715K Buy
11,136
+2,775
+33% +$159K 0.11% 98
2019
Q3
$424K Hold
8,361
0.08% 116
2019
Q2
$379K Buy
8,361
+950
+13% +$44.3K 0.07% 122
2019
Q1
$354K Hold
7,411
0.06% 125
2018
Q4
$385K Hold
7,411
0.08% 113
2018
Q3
$460K Buy
7,411
+425
+6% +$25.2K 0.08% 110
2018
Q2
$387K Sell
6,986
-231
-3% -$12.5K 0.07% 117
2018
Q1
$456K Sell
7,217
-400
-5% -$25.7K 0.09% 110
2017
Q4
$467K Hold
7,617
0.09% 111
2017
Q3
$486K Buy
7,617
+90
+1% +$5.25K 0.1% 110
2017
Q2
$419K Sell
7,527
-231
-3% -$12.6K 0.09% 115
2017
Q1
$422K Buy
7,758
+975
+14% +$53.5K 0.09% 116
2016
Q4
$396K Buy
6,783
+1,922
+40% +$105K 0.09% 115
2016
Q3
$262K Buy
4,861
+400
+9% +$25.7K 0.06% 128
2016
Q2
$328K Sell
4,461
-65
-1% -$4.59K 0.08% 116
2016
Q1
$289K Buy
4,526
+90
+2% +$5.68K 0.07% 117
2015
Q4
$305K Sell
4,436
-41
-0.9% -$2.71K 0.08% 107
2015
Q3
$265K Hold
4,477
0.07% 112
2015
Q2
$298K Sell
4,477
-922
-17% -$60.8K 0.08% 108
2015
Q1
$348K Sell
5,399
-525
-9% -$32.9K 0.09% 106
2014
Q4
$350K Hold
5,924
0.08% 118
2014
Q3
$303K Buy
5,924
+225
+4% +$11.2K 0.07% 124
2014
Q2
$276K Buy
5,699
+1,300
+30% +$64.1K 0.07% 132
2014
Q1
$229K Hold
4,399
0.06% 131
2013
Q4
$234K Hold
4,399
0.06% 130
2013
Q3
$204K Sell
4,399
-881
-17% -$38.7K 0.06% 131
2013
Q2
$236K Buy
+5,280
New +$229K 0.07% 122

Other funds holding BMY

Marble Harbor Investment Counsel's BMY Position: Q1 2026 in Review

Marble Harbor Investment Counsel held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 5,343 shares worth $324K. The position accounts for 0.04% of the portfolio, ranked #151.

Marble Harbor Investment Counsel first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.22M in Q4 2022. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Marble Harbor Investment Counsel held 5,343 shares of Bristol-Myers Squibb worth $324K as of Q1 2026.
  • Marble Harbor Investment Counsel left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up 0.04% of Marble Harbor Investment Counsel's portfolio in Q1 2026, its #151 holding.
  • Marble Harbor Investment Counsel first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Marble Harbor Investment Counsel's Bristol-Myers Squibb position peaked at $1.22M in Q4 2022.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Marble Harbor Investment Counsel's 13F filing for Q1 2026, filed 8 May 2026.